アキュルナ株式会社

AccuRna was established primarily to commercialize research developed at the University of Tokyo. Using its platform technology for delivering nucleic acids, particularly RNA, it provides drug discovery technologies and develops therapeutics for cancer and musculoskeletal diseases.